See more news releases in: Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals
Cardiogenesis Corporation to Report 2009 Fourth Quarter and Full-Year Results on March 3rd
IRVINE, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), announced that the company will release results for its fourth quarter and full-year ended December 31, 2009 on Wednesday March 3, 2010. The company added that Paul J. McCormick, its Executive Chairman, and William R. Abbott, its Senior Vice President and Chief Financial Officer, will host an investor conference call that day at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to review the company's financial results and business outlook.
The call is open to all interested investors through a live audio broadcast via the Internet at www.cardiogenesis.com. The call also will be available to investors and analysts by dialing (866) 510-0676 within the U.S. and Canada and (617) 597-5361 from abroad. The passcode is 35890330.
The webcast will be archived on the company's web site and will be available for playback for seven days beginning shortly after the live webcast. A telephonic playback of the conference call will be available beginning at 8:00 p.m. Eastern time on Wednesday, March 3, 2010, and continue through 8:00 p.m. Eastern time on Wednesday, March 10, 2010. The replay can be accessed by calling (888) 286-8010 within the U.S. and Canada and (617) 801-6888 from abroad. The replay passcode is 96086287.
About Cardiogenesis Corporation
Cardiogenesis is a medical device company specializing in the treatment of cardiovascular disease and is a leader in devices that stimulate cardiac angiogenesis. The company's market leading Holmium:YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina. Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease.
For more information on the company and its products, please visit the Cardiogenesis company website at www.cardiogenesis.com.
SOURCE Cardiogenesis Corporation
Back to top
RELATED LINKS
http://www.cardiogenesis.com
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All The Glitters: The Ultimate Gold Report".